Turkovac

Turkovac
Vaccine description
Target	SARS-CoV-2
Vaccine type	Inactivated
Clinical data
Other names	ERUCOV-VAC
Routes of; administration	Intramuscular
Legal status
Legal status	Full list of Turkovac authorizations;

Turkovac^[1](pronunciation:['tɜ:rkəvæk]) is aCOVID-19 vaccinedeveloped byTurkish Ministry of HealthandErciyes University.

Clinical trials

In November 2020, TURKOVAC started on phase I trials with 44 participants in Turkey.^[2]

In February 2021, TURKOVAC started on phase II trials with 250 participants in Turkey.^[3]

In June 2021, TURKOVAC started on phase III trials with 40,800 participants in Turkey.^[4]As of 2023^[update]phase III trials continue.^[5]

Authorization

On 25 November 2021, theTurkish Minister of Healthreported that Turkovac's application for emergency use authorization had been filed.^[6]On 22 December, Turkish PresidentRecep Tayyip Erdoganannounced the emergency use approval of Turkovac.^[7]

References

^Cakmak BN (22 June 2021)."Turkey names home-grown COVID-19 jab Turkovac".Anadolu Agency.
^Clinical trial numberNCT04691947for "Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC (ERUCOV-VAC)" atClinicalTrials.gov
^Clinical trial numberNCT04824391for "Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19" atClinicalTrials.gov
^"Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine".ClinicalTrials.gov.28 June 2021. NCT04942405.Retrieved29 June2021.
^"ClinicalTrials.gov".clinicaltrials.gov.Retrieved16 January2024.
^"Turkey issues emergency-use authorization for its domestically produced vaccine".The New York Times.22 December 2021.Retrieved28 December2021.
^"Turkey authorises use of own Turkovac Covid-19 vaccine".France 24.23 December 2021.Retrieved24 December2021.

Scholiahas a profile forTURKOVAC(Q106532118).

This article about COVID-19 vaccines is astub.You can help Wikipedia byexpanding it.

This article aboutvaccinesorvaccinationis astub.You can help Wikipedia byexpanding it.

[1] Cakmak BN (22 June 2021)."Turkey names home-grown COVID-19 jab Turkovac".Anadolu Agency.

[2] Clinical trial numberNCT04691947for "Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC (ERUCOV-VAC)" atClinicalTrials.gov

[3] Clinical trial numberNCT04824391for "Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19" atClinicalTrials.gov

[4] "Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine".ClinicalTrials.gov.28 June 2021. NCT04942405.Retrieved29 June2021.

[5] "ClinicalTrials.gov".clinicaltrials.gov.Retrieved16 January2024.

[6] "Turkey issues emergency-use authorization for its domestically produced vaccine".The New York Times.22 December 2021.Retrieved28 December2021.

[7] "Turkey authorises use of own Turkovac Covid-19 vaccine".France 24.23 December 2021.Retrieved24 December2021.

[1]

[2]

[3]

[4]

[5]

[6]

[7]